GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » Retained Earnings

M1 Kliniken AG (XTER:M12) Retained Earnings : €43.3 Mil (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. M1 Kliniken AG's retained earnings for the quarter that ended in Jun. 2023 was €43.3 Mil.

M1 Kliniken AG's quarterly retained earnings declined from Jun. 2022 (€38.8 Mil) to Dec. 2022 (€38.0 Mil) but then increased from Dec. 2022 (€38.0 Mil) to Jun. 2023 (€43.3 Mil).

M1 Kliniken AG's annual retained earnings increased from Dec. 2020 (€28.0 Mil) to Dec. 2021 (€37.4 Mil) and increased from Dec. 2021 (€37.4 Mil) to Dec. 2022 (€38.0 Mil).


M1 Kliniken AG Retained Earnings Historical Data

The historical data trend for M1 Kliniken AG's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M1 Kliniken AG Retained Earnings Chart

M1 Kliniken AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Retained Earnings
Get a 7-Day Free Trial Premium Member Only 18.20 22.68 28.01 37.40 38.00

M1 Kliniken AG Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.61 37.40 38.78 38.00 43.34

M1 Kliniken AG Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


M1 Kliniken AG  (XTER:M12) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


M1 Kliniken AG (XTER:M12) Business Description

Traded in Other Exchanges
Address
Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.
Executives
Kilian Brenske Board of Directors
Attila Strauss Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines